• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Episode 1 - The Changing Tides of Multiple Sclerosis: Where Do We Currently Stand?

Video

In a discussion moderated by Dr. Fred Lublin, Drs. Patricia K Coyle, Leslie Fish, and Gary M. Owens share their insights and perspectives on the increasing prevalence and incidence of multiple sclerosis (MS) worldwide, despite great clinical strides in recent years. United States is recognized as a high-risk zone for developing MS, and although previous estimates suggested that the US was limited to approximately 400,000 cases of MS, new data indicates that the prevalence may actually be closer to 750,000. MS tends to strike individuals during their peak productive years, causes chronic disability, and is associated with heavy disease and economic burden. As such, it is vital to expand the discussion of managed care strategies while continuing the exploration for optimal therapeutic amidst an evolving drug pipeline for MS.


Related Videos
James Robinson, PhD, MPH, University of California, Berkeley
James Robinson, PhD, MPH, University of California, Berkeley
Carrie Kozlowski
Kiana Mehring, MBA, director of strategic partnerships, managed care at Florida Cancer Specialists & Research Institute (FCS)
James Robinson, PhD, MPH, University of California, Berkeley
Carrie Kozlowski, OT, MBA
Chandler Cortina, MD, MS, FSSO, FACS | Image Credit: Froedtert & Medical College of Wisconsin
Miriam J. Atkins, MD, FACP, president of the Community Oncology Alliance (COA) and physician and partner of AO Multispecialty Clinic in Augusta, Georgia.
Carrie Kozlowski, OT, MBA
Shawn Gremminger
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.